Events & Presentations Events & Presentations Latest Corporate Presentation October 4, 2021 Checkmate Pharmaceuticals Corporate Overview – October 2021 Upcoming Events Jefferies KOL Webinar: Innate Immunity and Vidutolimod (CMP-001) Oct 26, 2021 at 11:00 AM EDT Click here for webcast Supporting Materials View slides: Overcoming challenges in innate immune activation: the unique effects of vidutolimod 11.8 MB Past Events Cantor Virtual Global Healthcare Conference Sep 30, 2021 at 10:40 AM EDT Click here for webcast H.C. Wainwright 23rd Annual Global Investment Conference Sep 13, 2021 at 7:00 AM EDT BTIG Virtual Biotechnology Conference Aug 9, 2021 at 3:30 PM EDT Presentations International Working Group on Melanoma 2021. Krieg, Art. View presentation recording: Vidutolimod: A virus-like particle delivering a Cp… STING & TLR-Targeting Therapies Summit 2021. Krieg, Art. View presentation recording: Role of Innate Immune Signals in Antitumor Immunit… ASCO 2021. Wong, Deborah, et al. Source Abstract TPS6089. CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab … View poster: CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + p… World Congress of Melanoma/EADO Congress 2021. Krieg, Art. View presentation recording: CMP-001, a CpG-A TLR9 agonist package in a virus-l… World Congress of Melanoma/EADO Congress 2021. Diwakar, Davar. View presentation: Neoadjuvant combinations with innate immunity stimulation World Congress of Melanoma/EADO Congress 2021. Ribas, Antoni, et al. Source Abstract P-119. View poster: CMP-001-010: An Open-Label, Phase 2 Study to Evaluate Intratumoura… World Congress of Melanoma/EADO Congress 2021. Davar, Diwakar, et al. Source Abstract P-074. View poster: CMP-001-011: First-Line Vidutolimod (CMP-001) Plus Nivolumab Versu… AACR 2021. Luke, Jason, et al. Source Abstract 5231. Vidutolimod (CMP-001) demonstrates improved response in noninflamed anti–PD-1 r… View slides: Vidutolimod (CMP-001) demonstrates improved response in noninflame… View presentation recording: Vidutolimod (CMP-001) demonstrates improved respon… SITC 2020. Davar, Diwakar, et al. Source Abstract 612. View poster: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (… View slides: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (… SITC 2020. Morris, Aaron, et al. Source Abstract 604. View poster: Intravenous CMP-001, a CpG-A Toll-like receptor 9 (TLR9) agonist d… Pagination Current page 1 Page 2 Next page next › Last page last »
Events & Presentations Latest Corporate Presentation October 4, 2021 Checkmate Pharmaceuticals Corporate Overview – October 2021 Upcoming Events Jefferies KOL Webinar: Innate Immunity and Vidutolimod (CMP-001) Oct 26, 2021 at 11:00 AM EDT Click here for webcast Supporting Materials View slides: Overcoming challenges in innate immune activation: the unique effects of vidutolimod 11.8 MB Past Events Cantor Virtual Global Healthcare Conference Sep 30, 2021 at 10:40 AM EDT Click here for webcast H.C. Wainwright 23rd Annual Global Investment Conference Sep 13, 2021 at 7:00 AM EDT BTIG Virtual Biotechnology Conference Aug 9, 2021 at 3:30 PM EDT Presentations International Working Group on Melanoma 2021. Krieg, Art. View presentation recording: Vidutolimod: A virus-like particle delivering a Cp… STING & TLR-Targeting Therapies Summit 2021. Krieg, Art. View presentation recording: Role of Innate Immune Signals in Antitumor Immunit… ASCO 2021. Wong, Deborah, et al. Source Abstract TPS6089. CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab … View poster: CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + p… World Congress of Melanoma/EADO Congress 2021. Krieg, Art. View presentation recording: CMP-001, a CpG-A TLR9 agonist package in a virus-l… World Congress of Melanoma/EADO Congress 2021. Diwakar, Davar. View presentation: Neoadjuvant combinations with innate immunity stimulation World Congress of Melanoma/EADO Congress 2021. Ribas, Antoni, et al. Source Abstract P-119. View poster: CMP-001-010: An Open-Label, Phase 2 Study to Evaluate Intratumoura… World Congress of Melanoma/EADO Congress 2021. Davar, Diwakar, et al. Source Abstract P-074. View poster: CMP-001-011: First-Line Vidutolimod (CMP-001) Plus Nivolumab Versu… AACR 2021. Luke, Jason, et al. Source Abstract 5231. Vidutolimod (CMP-001) demonstrates improved response in noninflamed anti–PD-1 r… View slides: Vidutolimod (CMP-001) demonstrates improved response in noninflame… View presentation recording: Vidutolimod (CMP-001) demonstrates improved respon… SITC 2020. Davar, Diwakar, et al. Source Abstract 612. View poster: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (… View slides: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (… SITC 2020. Morris, Aaron, et al. Source Abstract 604. View poster: Intravenous CMP-001, a CpG-A Toll-like receptor 9 (TLR9) agonist d… Pagination Current page 1 Page 2 Next page next › Last page last »
Jefferies KOL Webinar: Innate Immunity and Vidutolimod (CMP-001) Oct 26, 2021 at 11:00 AM EDT Click here for webcast Supporting Materials View slides: Overcoming challenges in innate immune activation: the unique effects of vidutolimod 11.8 MB
View slides: Overcoming challenges in innate immune activation: the unique effects of vidutolimod 11.8 MB
International Working Group on Melanoma 2021. Krieg, Art. View presentation recording: Vidutolimod: A virus-like particle delivering a Cp…
STING & TLR-Targeting Therapies Summit 2021. Krieg, Art. View presentation recording: Role of Innate Immune Signals in Antitumor Immunit…
ASCO 2021. Wong, Deborah, et al. Source Abstract TPS6089. CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab … View poster: CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + p…
CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab … View poster: CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + p…
World Congress of Melanoma/EADO Congress 2021. Krieg, Art. View presentation recording: CMP-001, a CpG-A TLR9 agonist package in a virus-l…
World Congress of Melanoma/EADO Congress 2021. Diwakar, Davar. View presentation: Neoadjuvant combinations with innate immunity stimulation
World Congress of Melanoma/EADO Congress 2021. Ribas, Antoni, et al. Source Abstract P-119. View poster: CMP-001-010: An Open-Label, Phase 2 Study to Evaluate Intratumoura…
World Congress of Melanoma/EADO Congress 2021. Davar, Diwakar, et al. Source Abstract P-074. View poster: CMP-001-011: First-Line Vidutolimod (CMP-001) Plus Nivolumab Versu…
AACR 2021. Luke, Jason, et al. Source Abstract 5231. Vidutolimod (CMP-001) demonstrates improved response in noninflamed anti–PD-1 r… View slides: Vidutolimod (CMP-001) demonstrates improved response in noninflame… View presentation recording: Vidutolimod (CMP-001) demonstrates improved respon…
Vidutolimod (CMP-001) demonstrates improved response in noninflamed anti–PD-1 r… View slides: Vidutolimod (CMP-001) demonstrates improved response in noninflame… View presentation recording: Vidutolimod (CMP-001) demonstrates improved respon…
SITC 2020. Davar, Diwakar, et al. Source Abstract 612. View poster: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (… View slides: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (…
View poster: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (… View slides: Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (…
SITC 2020. Morris, Aaron, et al. Source Abstract 604. View poster: Intravenous CMP-001, a CpG-A Toll-like receptor 9 (TLR9) agonist d…
